The Neurology group
Pomona, California, United States
Neurologist in Pomona, California
2895 N Towne Ave, Pomona, CA 91767
About The Neurology group
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
ACADIA Pharmaceuticals Inc.
1
Actelion
1
Amgen
1
Otsuka Pharmaceutical Development & Commercialization, Inc.
1
Clinical Trials at The Neurology group
During the past decade, The Neurology group conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on
average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury
2017-05-30
2022-08-31
Completed
168
Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis
2017-07-05
2024-01-18
Active, not recruiting
877
Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression
2018-03-09
2019-07-24
Completed
47
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
2021-01-15
2031-07-15
Recruiting
2,100
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
2021-04-28
2024-12-31
Recruiting
600
A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine
2021-06-11
2023-10-06
Recruiting
322
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Neurology group" #1 sponsor was "Pfizer" with 2 trials, followed by "ACADIA Pharmaceuticals Inc." with 1 trials
sponsored, "Actelion" with 1 trials sponsored, "Amgen" with 1 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
Clinical Trials Conditions at The Neurology group
According to Clinical.Site data, the most researched conditions in "The Neurology group" are
"Acute Treatment of Migraine" (1 trials), "Migraine" (1 trials), "Multiple Sclerosis" (1 trials), "Neurobehavioral Disinhibition" (1 trials) and "Pediatric Migraine" (1 trials). Many other conditions were trialed in "The Neurology group" in a lesser frequency.
Clinical Trials Intervention Types at The Neurology group
Most popular intervention types in "The Neurology group" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "AVP-786" (1 trials), "Erenumab" (1 trials), "Matching placebo" (1 trials), "Pimavanserin" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Neurology group
The vast majority of trials in "The Neurology group" are
6 trials for "All" genders.
Clinical Trials Status at The Neurology group
Currently, there are NaN active trials in "The Neurology group".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in The Neurology group,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in The Neurology group, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".